TherapeuticsMD jumps after swinging to profit

TherapeuticsMD

15/08/2022 14:24

** Drugmaker TherapeuticsMD's shares  TXMD.O  up 18.8% to
$10.95 before the bell
    ** Co reports a Q2 profit of $12.8/shr compared to a loss of
$5.41/shr last year, helped by a gain from the sale of its
vitaCare business  urn:newsml:reuters.com:*:nBw6rlYJva
    ** Revenues rise 24% to $28.6 mln on higher demand of its
pregnancy prevention treatment, Annovera  
    ** Up to Friday's close, stock was down 48% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))